Clinical trial
Pharmacokinetics Study on Nevirapine Resistance in Tanzania
NCT00294892 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00294892 |
|---|---|
| Title | Pharmacokinetics Study on Nevirapine Resistance in Tanzania |
| Official title | The Effect of Single Dose Carbamazepine on the Pharmacokinetics of Single Dose Nevirapine (Viramune, NVP) and Development of NVP Resistance, PMTCT Program of Moshi, Tanzania (VITA1) |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | carbamazepine and nevirapine, Nevirapine |
| Enrollment | 144 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Jun 1, 2010 |
| First posted | Feb 22, 2006 |
| Last update posted | Nov 30, 2020 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: